Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Sars-Cov-2 Infection and Severity in Patients With Hematologic Malignancies: A Systematic Review Publisher Pubmed



Seyedalinaghi S1 ; Karimi A2 ; Mirzapour P1 ; Salmani R3 ; Razi A2 ; Mojdeganlou H4 ; Mojdeganlou P5 ; Qodrati M1 ; Jashaninejad R6 ; Paranjkhoo P7 ; Dadras O8 ; Zarezadeh B1 ; Afsahi AM9 ; Afzalian A2 Show All Authors
Authors
  1. Seyedalinaghi S1
  2. Karimi A2
  3. Mirzapour P1
  4. Salmani R3
  5. Razi A2
  6. Mojdeganlou H4
  7. Mojdeganlou P5
  8. Qodrati M1
  9. Jashaninejad R6
  10. Paranjkhoo P7
  11. Dadras O8
  12. Zarezadeh B1
  13. Afsahi AM9
  14. Afzalian A2
  15. Varshochi S2
  16. Mehraeen E10
  17. Afsahi G11
Show Affiliations
Authors Affiliations
  1. 1. Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Midwifery, Khalkhal University of Medical Sciences, Khalkhal, Iran
  4. 4. Department of Pathology, Urmia University of Medical Sciences, Urmia, Iran
  5. 5. School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  6. 6. Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
  7. 7. Turpanjian College of Health Sciences, American University of Armenia, Yerevan, 0019, Armenia
  8. 8. Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway
  9. 9. Department of Radiology, School of Medicine, University of California, San Diego (UCSD), CA, United States
  10. 10. Department of Health Information Technology, Khalkhal University of Medical Sciences, Khalkhal, Iran
  11. 11. Department of Biotechnology Research, University of California, San Diego, United States

Source: Infectious Disorders - Drug Targets Published:2023


Abstract

Introduction: Earlier reports described the possibility of higher SARS-CoV-2 infection and severity in patients with hematological malignancies. Given the importance and incidence of these malignancies, we aimed to systematically review SARS-CoV-2 infection and severity in patients with hematologic cancers. Methods: We retrieved the relevant records by searching the keywords in online databases of PubMed, Web of Science, Cochrane, and Scopus on December 31st, 2021. A two-step screening; title/abstract and full-text screening, was employed to select the eligible studies. These eligible studies entered the final qualitative analysis. The study is adhered to the Preferred Reporting Items for Systematic Re-views and Meta-Analyses (PRISMA) checklist to ensure the reliability and validity of the results. Results: Forty studies concerning different hematologic malignancies and the effect of COVID-19 infection on them were included in the final analysis. The findings showed that in general, the prevalence of SARS-CoV-2 infection and the severity of the disease are often higher in hematologic malignancies and the patients could experience higher morbidity and mortality compared to general populations. Conclusion: It appeared that individuals with hematologic malignancies are more vulnerable to COVID-19 infection and they experience more severe disease with higher mortality rates. The presence of other comorbidities could also deteriorate this situation. Further investigation is recommended to evaluate the outcome of COVID-19 infection in different subtypes of hematologic malignancies. © 2023 Bentham Science Publishers.
Other Related Docs
15. Estimating the Size of the Hidden Population of Covid-19, Infectious Disorders - Drug Targets (2024)
16. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
20. The Psychological, Philosophical, and Political Implications of Covid-19, Infectious Disorders - Drug Targets (2023)
21. Sars-Cov-2 Infection in Cancer Patients, Susceptibility, Outcome and Care, American Journal of the Medical Sciences (2022)
23. Hearing Loss and Covid-19: An Umbrella Review, European Archives of Oto-Rhino-Laryngology (2023)
30. Gut Microbiota and Covid-19: A Systematic Review, Health Science Reports (2023)
34. Complications of Covid-19 Vaccines During Pregnancy; a Systematic Review, Archives of Academic Emergency Medicine (2022)
39. Can Waves of Autoimmune Diseases Occur After the Covid-19 Pandemic?, Infectious Disorders - Drug Targets (2024)
42. Obesity As an Independent Risk Factor for Covid-19 Severity and Mortality, Cochrane Database of Systematic Reviews (2023)